Deplorable Yankee
Diamond Member
- Banned
- #1

Distributed Denial of HCQ to COVID-19 Victims
Summary On March 19, at a White House briefing, President Trump “touted” chloroquine (hydroxychloroquine is chloroquine metabolite) for possible use against COVID-19. The very next day, a media ope…

Distributed Denial of HCQ to COVID-19 Victims
Leo Goldstein / 8 hours ago May 11, 2020
Summary
On March 19, at a White House briefing, President Trump “touted” chloroquine (hydroxychloroquine is chloroquine metabolite) for possible use against COVID-19. The very next day, a media operation was launched to deny this treatment to the public. Several fake news outlets published articles, saying things like this (NYT, March 20):
Referring to this as a media operation is appropriate because multiple outlets repeated the same false talking points. At that timeTrump’s Embrace of Unproven Drugs to Treat Coronavirus Defies Science
Doctors and patients also worry that the president’s rosy outlook for the treatments will exacerbate shortages of old malaria drugs relied on by patients with lupus and other debilitating conditions.
- The use of hydroxychloroquine for COVID-19 already had scientific support, although not to the level required for FDA approval of a new drug; but HCQ was already approved.
- The fact that hospitals had already been increasing their supply of HCQ and CQ before President’s briefing was an additional indication that medical professionals believed in the drugs’ usefulness against COVID-19.
- There were no shortages of HCQ or CQ for lupus & RA patients at that time.
- Multiple pharma companies announced an increase in HCQ manufacturing and substantial donations of HCQ.
- Even without these increases, the HCQ amounts required for COVID-19 patients were too small to impact the supply for other users.
Consequences of the anti-HCQ Media Operation
lil long read it all at link above ...cause we're all in this tooghehtherrrrrr